Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Thomas jefferson university (2)
- Adjuvant therapy; agitation; allergic disease; attention deficit disorder; behavior disorder; blindness; bradycardia; child care; clinical trial; cognitive defect; common cold; coughing; depression; diarrhea; drug blood level; drug efficacy; drug eruption; drug fatality; drug hypersensitivity; drug marketing; drug safety; drug surveillance program; drug withdrawal; dystonia; emotional disorder; epilepsy; febrile convulsion; glomerulus filtration; heart block; hostility; human; hyperkinesia; hypertension; hyponatremia; hypoplasia; hypotension; infection; irritability; liver dysfunction; liver metabolism; liver toxicity; mental disease; metabolic acidosis; metabolic syndrome X; muscle rigidity; nephrotoxicity; nocturnal enuresis; off label drug use; ovary polycystic disease; oxygen therapy; pancreatitis; patient education; patient monitoring; pediatric anesthesia; postmarketing surveillance; prematurity; prescription; priority journal; psychopharmacology; psychosis; respiration depression; retrolental fibroplasia; review; risk assessment; seizure; side effect; Stevens Johnson syndrome; suicidal behavior; suicidal ideation; suicide attempt; thyroid disease; tooth disease; treatment indication; tremor; upper respiratory tract infection; weight gain; alpha adrenergic receptor stimulating agent; amfebutamone; amphetamine; anticonvulsive agent; antidepressant agent; atomoxetine; atypical antipsychotic agent; chloramphenicol; chlordiazepoxide; desmopressin; diazepam; fluoxetine; flurazepam; haloperidol; lamotrigine; lithium derivative; loxapine; neuroleptic agent; olanzapine; pemoline; phenobarbital; placebo; promethazine; propofol; risperidone; serotonin uptake inhibitor; tricyclic antidepressant agent; unindexed drug; valproate semisodium; valproic acid; Thomas Jefferson University; Department of Psychiatry and Human Behavior (1)
- Adolescents (1)
- Age-Related Macular Degeneration (1)
- Clinical Trial (1)
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health
Improving Function In Age-Related Macular Degeneration: Design And Methods Of A Randomized Clinical Trial., Barry W Rovner, Robin J Casten, Mark T Hegel, Robert W Massof, Benjamin E Leiby, William S Tasman
Improving Function In Age-Related Macular Degeneration: Design And Methods Of A Randomized Clinical Trial., Barry W Rovner, Robin J Casten, Mark T Hegel, Robert W Massof, Benjamin E Leiby, William S Tasman
Department of Psychiatry and Human Behavior Faculty Papers
Age-Related Macular Degeneration (AMD) is the leading cause of severe vision loss in older adults and impairs the ability to read, drive, and live independently and increases the risk for depression, falls, and earlier mortality. Although new medical treatments have improved AMD's prognosis, vision-related disability remains a major public health problem. Improving Function in AMD (IF-AMD) is a two-group randomized, parallel design, controlled clinical trial that compares the efficacy of Problem-Solving Therapy (PST) with Supportive Therapy (ST) (an attention control treatment) to improve vision function in 240 patients with AMD. PST and ST therapists deliver 6 one-hour respective treatment sessions …
Universal Or Indicated Screening In Primary Care?, Matthew Wintersteen, Md
Universal Or Indicated Screening In Primary Care?, Matthew Wintersteen, Md
Department of Psychiatry and Human Behavior Faculty Papers
To the Editor: In the November 2010 issue, Schmitt and colleagues (1) reported that the duration of visits increased when depression screening was conducted in primary care. This report is timely given recent recommendations for both adult and pediatric screening for depression in primary care. Schmitt and colleagues examined data representative of more than 641 million primary care visits in2005–2007 and found that when depression screening was documented in patients’ records, physicians’ time with patients increased significantly.
Attachment-Based Family Therapy For Adolescents With Suicidal Ideation: A Randomized Controlled Trial., Guy S. Diamond, Matthew B. Wintersteen, Gregory K. Brown, Gary M. Diamond, Robert Gallop, Karni Shelef, Suzanne Levy
Attachment-Based Family Therapy For Adolescents With Suicidal Ideation: A Randomized Controlled Trial., Guy S. Diamond, Matthew B. Wintersteen, Gregory K. Brown, Gary M. Diamond, Robert Gallop, Karni Shelef, Suzanne Levy
Department of Psychiatry and Human Behavior Faculty Papers
OBJECTIVE: To evaluate whether Attachment-Based Family Therapy (ABFT) is more effective than Enhanced Usual Care (EUC) for reducing suicidal ideation and depressive symptoms in adolescents. METHOD: This was a randomized controlled trial of suicidal adolescents between the ages of 12 and 17, identified in primary care and emergency departments. Of 341 adolescents screened, 66 (70% African American) entered the study for 3 months of treatment. Assessment occurred at baseline, 6 weeks, 12 weeks, and 24 weeks. ABFT consisted of individual and family meetings, and EUC consisted of a facilitated referral to other providers. All participants received weekly monitoring and access …
Off-Label Psychopharmacologic Prescribing For Children: History Supports Close Clinical Monitoring., Julie M Zito, Albert T Derivan, Christopher J Kratochvil, Daniel J Safer, Joerg M Fegert, Laurence L Greenhill
Off-Label Psychopharmacologic Prescribing For Children: History Supports Close Clinical Monitoring., Julie M Zito, Albert T Derivan, Christopher J Kratochvil, Daniel J Safer, Joerg M Fegert, Laurence L Greenhill
Department of Psychiatry and Human Behavior Faculty Papers
The review presents pediatric adverse drug events from a historical perspective and focuses on selected safety issues associated with off-label use of medications for the psychiatric treatment of youth. Clinical monitoring procedures for major psychotropic drug classes are reviewed. Prior studies suggest that systematic treatment monitoring is warranted so as to both minimize risk of unexpected adverse events and exposures to ineffective treatments. Clinical trials to establish the efficacy and safety of drugs currently being used off-label in the pediatric population are needed. In the meantime, clinicians should consider the existing evidence-base for these drugs and institute close clinical monitoring.